Globe-spanning clinical trial for pre-XDR-TB

The trial enrolled 324 patients in six countries across study sites managed by Interactive Research and Development, Médecins Sans Frontières, and Partners In Health, in collaboration with researchers and clinicians at HMS and Brigham and Women’s Hospital and other academic medical centers and research hubs around the world. The countries are India, Kazakhstan, Lesotho, Pakistan, Peru, and Vietnam.